Skip to main content
PMC home page
Gut logoLink to Gut
. 1985 Feb;26(2):109–113. doi: 10.1136/gut.26.2.109

D-penicillamine for primary biliary cirrhosis.

O F James
PMCID: PMC1432437  PMID: 3881322

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Deering T. B., Dickson E. R., Fleming C. R., Geall M. G., McCall J. T., Baggenstoss A. H. Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis. Gastroenterology. 1977 Jun;72(6):1208–1212. [PubMed] [Google Scholar]
  2. Deshmukh K., Nimni M. E. A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. II. Functional groups involved in the interaction process. J Biol Chem. 1969 Apr 10;244(7):1787–1795. [PubMed] [Google Scholar]
  3. Epstein O., Arborgh B., Sagiv M., Wroblewski R., Scheuer P. J., Sherlock S. Is copper hepatotoxic in primary biliary cirrhosis? J Clin Pathol. 1981 Oct;34(10):1071–1075. doi: 10.1136/jcp.34.10.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Epstein O., De Villiers D., Jain S., Potter B. J., Thomas H. C., Sherlock S. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. N Engl J Med. 1979 Feb 8;300(6):274–278. doi: 10.1056/NEJM197902083000602. [DOI] [PubMed] [Google Scholar]
  5. Epstein O., Jain S., Lee R. G., Cook D. G., Boss A. M., Scheuer P. J., Sherlock S. D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet. 1981 Jun 13;1(8233):1275–1277. doi: 10.1016/s0140-6736(81)92456-9. [DOI] [PubMed] [Google Scholar]
  6. Fleming C. R., Dickson E. R., Baggenstoss A. H., McCall J. T. Copper and primary biliary cirrhosis. Gastroenterology. 1974 Dec;67(6):1182–1187. [PubMed] [Google Scholar]
  7. Goldberg M. J., Kaplan M. M., Mitamura T., Anderson C. L., Matloff D. S., Pinn V. W., Agnello V. Evidence against an immune complex pathogenesis of primary biliary cirrhosis. Gastroenterology. 1982 Sep;83(3):677–683. [PubMed] [Google Scholar]
  8. James O., Macklon A. F., Watson A. J. Primary biliary cirrhosis--a revised clinical spectrum. Lancet. 1981 Jun 13;1(8233):1278–1281. doi: 10.1016/s0140-6736(81)92457-0. [DOI] [PubMed] [Google Scholar]
  9. Matloff D. S., Alpert E., Resnick R. H., Kaplan M. M. A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med. 1982 Feb 11;306(6):319–326. doi: 10.1056/NEJM198202113060602. [DOI] [PubMed] [Google Scholar]
  10. Neuberger J., Christensen E., Portmann B., Caballeria J., Rodes J., Ranek L., Tygstrup N., Williams R. Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut. 1985 Feb;26(2):114–119. doi: 10.1136/gut.26.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Roll J., Boyer J. L., Barry D., Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med. 1983 Jan 6;308(1):1–7. doi: 10.1056/NEJM198301063080101. [DOI] [PubMed] [Google Scholar]
  13. Sherlock S., Scheuer P. J. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973 Sep 27;289(13):674–678. doi: 10.1056/NEJM197309272891306. [DOI] [PubMed] [Google Scholar]
  14. Taal B. G., Schalm S. W., Ten Kate F. W., Van Berge Henegouwen G. P., Brandt K. H. Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis. Liver. 1983 Dec;3(6):345–352. doi: 10.1111/j.1600-0676.1983.tb00887.x. [DOI] [PubMed] [Google Scholar]
  15. WALSHE J. M. Treatment of Wilson's disease with penicillamine. Lancet. 1960 Jan 23;1(7117):188–192. doi: 10.1016/s0140-6736(60)90109-4. [DOI] [PubMed] [Google Scholar]
  16. Wands J. R., Dienstag J. L., Bhan A. K., Feller E. R., Isselbacher K. J. Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med. 1978 Feb 2;298(5):233–237. doi: 10.1056/NEJM197802022980502. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES